Healthleap, a startup that scans hospital electronic health records overnight to flag patients who may have conditions doctors have missed, has raised $38 million across a seed and Series A round, the company confirmed this week. The financing arrives as the five-year-old company has grown from three hospital customers to more than 50 over the past year, with revenue climbing more than tenfold in the same stretch.
From Dietitian Side Project to Hospital-Wide Risk Engine
Healthleap was founded in South Africa in 2022 by siblings Josiah and Jemima Meyer, with Josiah serving as chief executive. The company’s origins were narrow: Jemima originally built a clinical nutrition tool for dietitians. That tool evolved into a much broader platform designed to catch hospital conditions, starting with malnutrition and delirium, that are often diagnosed late or missed entirely during a patient’s stay. The $38 million raise breaks down into an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company has not disclosed its valuation.
How the AI Reads Between the Lines of Clinical Notes
Healthleap’s system connects directly to a hospital’s electronic health record and runs every adult inpatient through its models each night. Rather than relying solely on structured data like lab results and vital signs, the company uses language models to pull out symptom mentions buried in free-text clinician notes, things like unexplained weight loss or difficulty swallowing, that might never get coded as a formal diagnosis. By morning, care teams see a risk score and trend dashboard built into their existing workflow. The company is explicit that the tool does not diagnose patients; it flags cases for human review, leaving the clinical judgment to doctors and nurses.
Expanding Beyond Malnutrition and Delirium
Malnutrition and delirium are currently Healthleap’s two live use cases, chosen in part because research suggests 20 to 50 percent of hospital inpatients are malnourished, a condition linked to longer hospital stays, higher infection rates, and increased mortality when it goes unaddressed. The company is now running clinical validation on three additional conditions: aspiration pneumonia, pressure ulcers, and congestive heart failure readmission risk. Its longer-term ambition is to extend the same approach to more than 40 major conditions and eventually move beyond inpatient care into outpatient and home settings.
A Pricing Model Tied to Financial Outcomes, Not Just Software Fees
Healthleap sells three-year contracts priced according to a hospital’s licensed bed count, but the more notable feature is an outcome-based guarantee: the company commits to delivering financial returns as a multiple of what hospitals pay for the software. Healthleap says every customer has achieved at least 5x hard return on investment, with some exceeding 20x in total annual ROI once reimbursement gains and reduced length-of-stay are factored in. At the Hospital of the University of Pennsylvania, the company’s malnutrition program is credited with $23.8 million in annualized financial impact, split between $6.3 million in additional reimbursement and $17.5 million attributed to shorter patient stays.
Customer List Signals Momentum Among Major Health Systems
Healthleap’s current customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare, a roster that spans some of the largest academic and regional health systems in the country. That growth, from a handful of pilot hospitals to more than 50 paying customers within a year, has fueled investor interest in a crowded field of AI tools competing for hospital IT budgets, many of which struggle to prove measurable financial return rather than just clinical promise.
What the Funding Will Support
Healthleap says the new capital will go toward engineering, product development, sales, and customer success, as well as building out support for additional conditions beyond its current pipeline. With reimbursement pressure and staffing shortages pushing hospitals to look for software that pays for itself, Healthleap’s bet is that proving hard financial ROI, rather than just better documentation or compliance, will be what separates it from the broader wave of clinical AI startups chasing hospital contracts.
Photo: sasint / PIXABAY via Pixabay
